FRI0730-HPR The concept of patient centered care in spondyloarthritis based on a multidisciplinary model

Background:Spondyloarthritis (SpA) is one the most prevalent musculoskeletal disease in the Americas, with an estimated prevalence of 0.5%. This group of patients presents a number of unmet needs for accessibility to the consultation, diagnosis and adequate treatments. That for this reason it is nec...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 77; no. Suppl 2; p. 1812
Main Authors Santos-Moreno, P., Villarreal, L., Buitrago-Garcia, D., Cabrera, M.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Limited 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background:Spondyloarthritis (SpA) is one the most prevalent musculoskeletal disease in the Americas, with an estimated prevalence of 0.5%. This group of patients presents a number of unmet needs for accessibility to the consultation, diagnosis and adequate treatments. That for this reason it is necessary to develop a program of Centers of Excellence (CoE), which allows answer to these needs and at the same time to add values for our health systems.Objectives:The aim was to create a program with pilot SpA centers initially in some countries that operate under the scheme of CoE, as they are already delineated in projects like REAL-PANLAR for rheumatoid arthritis. In a second phase and under the auspices of PANLAR (Panamerican league of associations for rheumatology) create a Pan American Network of Centers of Excellence in SpA (CESPA).Methods:We performed a systematic review of the literature in global and regional databases (Pubmed, Medline, Scopus, Lilacs), in order to search information on this research question-hypothesis. Subsequently and under a Delphi-modified methodology and consensus of involved rheumatologists lay the conceptual bases on this particular subject – the Centers of Excellence in SpA (CESPA). As a result of the above was defined as should be a CESPA.Results:In accordance with the principles of creation and operation of the CoE in particular, specific themes were developed by a coordinator who, after a review of the literature, presented a specific proposal on every particular topic that was discussed and then voted on and implemented swithin the CESPA concepts. A CESPA must have: 1. Screening Clinic and Early Diagnosis of SpA: the purpose is to rule out false positives of disease and to diagnose early SpA; 2. Model of patient-centered care: a model of frequencies of care should be implemented for SpA patients from the perspective of the different specialties involved in the multidisciplinary team; 3. Laboratories and images: conventional laboratory tests as having a minimum of 3–4 times a year and each patient will have conventional X-ray images of cervical and lumbosacral column at the beginning and then once a year. Ultrasound of entheses: upon admission to the program and then with a certain periodicity (annual) or depending of sensitivity to change (OMERACT). The same applies to the subject of MRI of sacroiliac joints and column for both diagnosis and follow-up; 4. Clinical guideline on SpA should be adapted and customized to the particular realities of some of our countries; 5. There must be a management (disease management) program that must include Structure, Process and Result Indicators to define CESPA as Standard, Optimal and Model; 6. There must be standardized education and research programs for patients and physicians at the centerConclusions:There is a global need to develop CESPAs, in order to define treatment targets type T2T-SpA, which would improve clinical outcomes and avoid so much disability and health economic costs.References1. Santos-Moreno P, et al. REAL-PANLAR Project for the Implementation and Accreditation of Centers of Excellence in RA Throughout Latin America. J Clin Rheumatol2015Jun;21(4):175–80.2. Santos-Moreno P, et al. From the model of integral attention to the creation of centers of excellence in RA. Clin Rheumatol. 2015Mar;34(Suppl 1):S71–7.Disclosure of Interest:None declared
AbstractList Background:Spondyloarthritis (SpA) is one the most prevalent musculoskeletal disease in the Americas, with an estimated prevalence of 0.5%. This group of patients presents a number of unmet needs for accessibility to the consultation, diagnosis and adequate treatments. That for this reason it is necessary to develop a program of Centers of Excellence (CoE), which allows answer to these needs and at the same time to add values for our health systems.Objectives:The aim was to create a program with pilot SpA centers initially in some countries that operate under the scheme of CoE, as they are already delineated in projects like REAL-PANLAR for rheumatoid arthritis. In a second phase and under the auspices of PANLAR (Panamerican league of associations for rheumatology) create a Pan American Network of Centers of Excellence in SpA (CESPA).Methods:We performed a systematic review of the literature in global and regional databases (Pubmed, Medline, Scopus, Lilacs), in order to search information on this research question-hypothesis. Subsequently and under a Delphi-modified methodology and consensus of involved rheumatologists lay the conceptual bases on this particular subject – the Centers of Excellence in SpA (CESPA). As a result of the above was defined as should be a CESPA.Results:In accordance with the principles of creation and operation of the CoE in particular, specific themes were developed by a coordinator who, after a review of the literature, presented a specific proposal on every particular topic that was discussed and then voted on and implemented swithin the CESPA concepts. A CESPA must have: 1. Screening Clinic and Early Diagnosis of SpA: the purpose is to rule out false positives of disease and to diagnose early SpA; 2. Model of patient-centered care: a model of frequencies of care should be implemented for SpA patients from the perspective of the different specialties involved in the multidisciplinary team; 3. Laboratories and images: conventional laboratory tests as having a minimum of 3–4 times a year and each patient will have conventional X-ray images of cervical and lumbosacral column at the beginning and then once a year. Ultrasound of entheses: upon admission to the program and then with a certain periodicity (annual) or depending of sensitivity to change (OMERACT). The same applies to the subject of MRI of sacroiliac joints and column for both diagnosis and follow-up; 4. Clinical guideline on SpA should be adapted and customized to the particular realities of some of our countries; 5. There must be a management (disease management) program that must include Structure, Process and Result Indicators to define CESPA as Standard, Optimal and Model; 6. There must be standardized education and research programs for patients and physicians at the centerConclusions:There is a global need to develop CESPAs, in order to define treatment targets type T2T-SpA, which would improve clinical outcomes and avoid so much disability and health economic costs.References1. Santos-Moreno P, et al. REAL-PANLAR Project for the Implementation and Accreditation of Centers of Excellence in RA Throughout Latin America. J Clin Rheumatol2015Jun;21(4):175–80.2. Santos-Moreno P, et al. From the model of integral attention to the creation of centers of excellence in RA. Clin Rheumatol. 2015Mar;34(Suppl 1):S71–7.Disclosure of Interest:None declared
Background: Spondyloarthritis (SpA) is one the most prevalent musculoskeletal disease in the Americas, with an estimated prevalence of 0.5%. This group of patients presents a number of unmet needs for accessibility to the consultation, diagnosis and adequate treatments. That for this reason it is necessary to develop a program of Centers of Excellence (CoE), which allows answer to these needs and at the same time to add values for our health systems. Objectives: The aim was to create a program with pilot SpA centers initially in some countries that operate under the scheme of CoE, as they are already delineated in projects like REAL-PANLAR for rheumatoid arthritis. In a second phase and under the auspices of PANLAR (Panamerican league of associations for rheumatology) create a Pan American Network of Centers of Excellence in SpA (CESPA). Methods: We performed a systematic review of the literature in global and regional databases (Pubmed, Medline, Scopus, Lilacs), in order to search information on this research question-hypothesis. Subsequently and under a Delphi-modified methodology and consensus of involved rheumatologists lay the conceptual bases on this particular subject - the Centers of Excellence in SpA (CESPA). As a result of the above was defined as should be a CESPA. Results: In accordance with the principles of creation and operation of the CoE in particular, specific themes were developed by a coordinator who, after a review of the literature, presented a specific proposal on every particular topic that was discussed and then voted on and implemented swithin the CESPA concepts. A CESPA must have: 1. Screening Clinic and Early Diagnosis of SpA: the purpose is to rule out false positives of disease and to diagnose early SpA; 2. Model of patient-centered care: a model of frequencies of care should be implemented for SpA patients from the perspective of the different specialties involved in the multidisciplinary team; 3. Laboratories and images: conventional laboratory tests as having a minimum of 3-4 times a year and each patient will have conventional X-ray images of cervical and lumbosacral column at the beginning and then once a year. Ultrasound of entheses: upon admission to the program and then with a certain periodicity (annual) or depending of sensitivity to change (OMERACT). The same applies to the subject of MRI of sacroiliac joints and column for both diagnosis and follow-up; 4. Clinical guideline on SpA should be adapted and customized to the particular realities of some of our countries; 5. There must be a management (disease management) program that must include Structure, Process and Result Indicators to define CESPA as Standard, Optimal and Model; 6. There must be standardized education and research programs for patients and physicians at the center Conclusions: There is a global need to develop CESPAs, in order to define treatment targets type T2T-SpA, which would improve clinical outcomes and avoid so much disability and health economic costs. References 1. Santos-Moreno P, et al. REAL-PANLAR Project for the Implementation and Accreditation of Centers of Excellence in RA Throughout Latin America. J Clin Rheumatol2015Jun;21(4):175-80. 2. Santos-Moreno P, et al. From the model of integral attention to the creation of centers of excellence in RA. Clin Rheumatol. 2015Mar;34(Suppl 1):S71-7. Disclosure of Interest: None declared
Author Villarreal, L.
Buitrago-Garcia, D.
Cabrera, M.
Santos-Moreno, P.
Author_xml – sequence: 1
  givenname: P.
  surname: Santos-Moreno
  fullname: Santos-Moreno, P.
  organization: Epidemiology, Biomab, Center For Rheumatoid Arthritis, Bogota, Bogota, Colombia
– sequence: 2
  givenname: L.
  surname: Villarreal
  fullname: Villarreal, L.
  organization: Epidemiology, Biomab, Center For Rheumatoid Arthritis, Bogota, Bogota, Colombia
– sequence: 3
  givenname: D.
  surname: Buitrago-Garcia
  fullname: Buitrago-Garcia, D.
  organization: Epidemiology, Biomab, Center For Rheumatoid Arthritis, Bogota, Bogota, Colombia
– sequence: 4
  givenname: M.
  surname: Cabrera
  fullname: Cabrera, M.
  organization: Epidemiology, Biomab, Center For Rheumatoid Arthritis, Bogota, Bogota, Colombia
BookMark eNqVkL1OwzAQxy1UJNrCO1jqnHLOh5OICVWUVqoEqspsOc5VdZXYwU6Gbiy8KE-CSxlYWe77f3f6TcjIWIOEzBjMGUv4vTTGHXBoa-2jGFgR4dBIN89TXl6RMUt5EcocRmQMAEmUljy_IRPvjyGFghVjclxu15AnEK1et18fn7sDUmWNwq6ndk872Ws0PVXBoMOaKumQakN9Z019aqx0_cHpXntaSR_61lBJ26HpdXhJ6a7RRroTbW2NzS253svG492vn5K35dNusYo2L8_rxeMmqlgBZZTUeSxZWbIskdleJVXGWIa5LFJEYFCg5EqlVYEsLZOsjmsOCisOVYohllUyJbPL3s7Z9wF9L452cCacFDHkjPEMeBymHi5TylnvHe5F53QbnhUMxBmu-ANXnOGKH7jiDDeo-UVdtcd_Cb8BR1aJJQ
ContentType Journal Article
Copyright 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright: 2018 © 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml – notice: 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Copyright: 2018 © 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
88I
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9-
K9.
LK8
M0R
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.1136/annrheumdis-2018-eular.7469
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Consumer Health Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle CrossRef
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList
ProQuest Central Student
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2060
ExternalDocumentID 10_1136_annrheumdis_2018_eular_7469
annrheumdis
GroupedDBID ---
.55
.GJ
.VT
169
23M
2WC
39C
3O-
4.4
40O
53G
5GY
5RE
5VS
6J9
7X7
7~S
88E
88I
8AF
8FE
8FH
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAXUO
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACPRK
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AEKJL
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
AKKEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BKNYI
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DWQXO
E3Z
EBS
EJD
F5P
FDB
FYUFA
GNUQQ
H13
HAJ
HCIFZ
HMCUK
HYE
HZ~
IAO
IEA
IHR
INH
INR
IOF
ITC
J5H
K9-
KQ8
L7B
LK8
M0R
M1P
M2P
M7P
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
RWL
RXW
TAE
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
VVN
W2D
W8F
WH7
WOQ
X6Y
X7M
YFH
YOC
YQY
ZGI
ZXP
AAFWJ
AALRI
AAYXX
CITATION
PHGZM
3V.
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-b1809-3d72a199153a5fc3b5115e7a84ee0108ea6cc4b8e14935d2d60ceb60b4e2d6ab3
IEDL.DBID 7X7
ISSN 0003-4967
IngestDate Fri Jul 25 11:13:00 EDT 2025
Tue Jul 01 01:56:18 EDT 2025
Thu Apr 24 23:02:25 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Suppl 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b1809-3d72a199153a5fc3b5115e7a84ee0108ea6cc4b8e14935d2d60ceb60b4e2d6ab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1812.2.full.pdf
PQID 2071165062
PQPubID 2041045
ParticipantIDs proquest_journals_2071165062
crossref_primary_10_1136_annrheumdis_2018_eular_7469
bmj_primary_10_1136_annrheumdis_2018_eular_7469
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180600
2018-06-00
20180601
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 20180600
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
PublicationTitle Annals of the rheumatic diseases
PublicationYear 2018
Publisher Elsevier Limited
Publisher_xml – name: Elsevier Limited
SSID ssj0000818
Score 2.251535
Snippet Background:Spondyloarthritis (SpA) is one the most prevalent musculoskeletal disease in the Americas, with an estimated prevalence of 0.5%. This group of...
Background: Spondyloarthritis (SpA) is one the most prevalent musculoskeletal disease in the Americas, with an estimated prevalence of 0.5%. This group of...
SourceID proquest
crossref
bmj
SourceType Aggregation Database
Index Database
Publisher
StartPage 1812
SubjectTerms Diagnosis
Inflammatory diseases
Joint diseases
Laboratories
Literature reviews
Magnetic resonance imaging
Musculoskeletal diseases
Patients
Periodicity
Research programs
Rheumatic diseases
Rheumatoid arthritis
Ultrasound
Title FRI0730-HPR The concept of patient centered care in spondyloarthritis based on a multidisciplinary model
URI http://ard.bmj.com/content/77/Suppl_2/1812.2.full
https://www.proquest.com/docview/2071165062
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFA-6wfAifuJ0joBeo1ubNtlJVDamsDGGg91K0qRswtq5j__f97IU3UXw1tL08t7L-8ov70fIvWoLwzvKsozHEYMIpZmEuMgs5B5SmNQYx9YwGMb9CX-fRlPfcFt7WGXpE52jNkWKPXLshOCkmFYcPC2_GLJG4emqp9A4JFUcXYaQLjEVP55YtmXJmMc7saiRO89igiQvq5ndLsx8DYbSlswi6vNBcEQ-H-rF536c2nfTLvb0TsixTxrp807Lp-TA5mekNvDH4udk1hu_4SZi_dGYguJpuruMSIuM-sGpFFGYyMtJEetF5zlFbKyBch1sZ-YmG1GMaIYWOVXU4Qx_39iljjLngkx63Y_XPvMUCkzjYC4WGhEoRDdFoYqyNNSQX0VWKMmthUpMWhWnKdfSQqEURiYwcSu1Om5pbuFZ6fCSVPIit1eEQiTPpMb5eynULCpTqmMiSD4CAe-ax3XyCGJLlrshGYkrLkJ34bkUdIKCTpygExR0nfBSxP_7rVGqI_EbDteU5nH99-cbcuT07RopDVLZrLb2FvKKjW4642mS6kt3OBp_A0Lkzk0
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JTsMwEB1BkYALYhU7loCjoU2cxD0gxFa1QCtUgcQt2LGjFtGkbEL8FN_IjJsIuCBx4JYoy2H87Jmx38wD2FG1yIi6sjwVYcDRQ2ku0S9yi7GHjExijFNraHfC5o04vw1ux-CjrIUhWmW5JrqF2uQJ7ZHTTgh1iqmG3uHwkZNqFJ2ulhIaI1hc2Pc3TNmeD1qnOL67ntc4uz5p8kJVgGvqVcV9E3mKCD-Br4I08TWGHIGNlBTWYnIirQqTRGhpMXfwA-OZsJpYHVa1sHittI__HYcJ4WMqU4GJ47POVfdr7Zc1WWr0iXoYTcJ2oZtCsjJPPfs6MP1nhGZNcks8071IENd6XA_uf3rGn47BebvGLMwUYSo7GuFqDsZsNg-T7eIgfgF6jW6Lpi1vXnUZQo0lo_JHlqesaNXKiPdJSqCM2GWsnzFi45r3hxzR2nO9lBj5UMPyjCnmmI3fa4SZE-lZhJt_Me8SVLI8s8vAMHZIpaaOfwlmSSpVqm4CDHe8CO-1CFdgH80WD0dtOWKXzviuxLo0dEyGjp2hYzL0CojSxH_7bL0cjriY4vROCcjV3x9vwVTzun0ZX7Y6F2sw7cbebeOsQ-Xl6dVuYFTzojcLKDG4-2_0fgIatwrb
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LS8QwEB50hcWL-MT1GVCP0d02bbIHEVGXXV-IKOytJk3KKtquL8S_5q9zJtuiXgQP3lr6OEy-ZGaSb-YD2NQtaUVbO56JOOLooQxX6Be5w9hDSZta69Uazs7j7rU47kf9MfioamGIVlmtiX6htkVKe-S0E0KdYppxsJOVtIiLw87e8JGTghSdtFZyGiOInLj3N0zfnnd7hzjWW0HQObo66PJSYYAb6lvFQysDTeSfKNRRloYGw4_ISa2Ec5ioKKfjNBVGOcwjwsgGNm6mzsRNIxxeaxPif8dhQoZRi-aY7MsvL6BaqlLrE-1Y1mGjVFAhgZmngXt9sLfPCNKW4o4Yp9tSEOt63Dzc_fSRP12E93udaZgqA1a2P0LYDIy5fBbqZ-WR_BwMOpc9msC8e3HJEHQsHRVCsiJjZdNWRgxQ0gRlxDNjtzkjXq59vy8QtwPfVYmRN7WsyJlmnuP4vVqYebmeebj-F-MuQC0vcrcIDKOITBnq_ZdivqQzrds2wsAnkHhvRNyAHTRbMhw16Eh8YhP6YuvK0AkZOvGGTsjQDRCVif_22Uo1HEk52emdCppLvz9ehzpiNjntnZ8sw6Qfer-fswK1l6dXt4rhzYtZ8zhicPPfwP0EpNMNqw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FRI0730-HPR%E2%80%85The+concept+of+patient+centered+care+in+spondyloarthritis+based+on+a+multidisciplinary+model&rft.jtitle=Annals+of+the+rheumatic+diseases&rft.au=Santos-Moreno%2C+P.&rft.au=Villarreal%2C+L.&rft.au=Buitrago-Garcia%2C+D.&rft.au=Cabrera%2C+M.&rft.date=2018-06-01&rft.issn=0003-4967&rft.volume=77&rft.spage=1812&rft_id=info:doi/10.1136%2Fannrheumdis-2018-eular.7469&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_annrheumdis_2018_eular_7469
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon